Chargement en cours...
TrkC-Targeted Kinase Inhibitors And PROTACs
A small molecule motif (IY–IY), which binds the tropomyosin receptor kinase C (TrkC), was used to deliver the promiscuous kinase inhibitor (KI) dasatinib into breast cancer. Conjugates with noncleavable (1) and cleavable (2) linkers were compared in cellular assays and shown to have more impact on t...
Enregistré dans:
| Publié dans: | Mol Pharm |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034693/ https://ncbi.nlm.nih.gov/pubmed/31512882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.9b00673 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|